美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=BLA021081"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
0955-1728-05 0955-1728 HUMAN PRESCRIPTION DRUG Insulin Glargine Solostar insulin glargine INJECTION, SOLUTION SUBCUTANEOUS 20220502 20251231 BLA BLA021081 Winthrop U.S. INSULIN GLARGINE 100 [iU]/mL 5 SYRINGE in 1 CARTON (0955-1728-05) / 3 mL in 1 SYRINGE (0955-1728-01)
0955-1729-01 0955-1729 HUMAN PRESCRIPTION DRUG Insulin Glargine insulin glargine INJECTION, SOLUTION SUBCUTANEOUS 20220502 20260331 BLA BLA021081 Winthrop U.S. INSULIN GLARGINE 100 [iU]/mL 1 VIAL, GLASS in 1 CARTON (0955-1729-01) / 10 mL in 1 VIAL, GLASS
50090-6184-0 50090-6184 HUMAN PRESCRIPTION DRUG Insulin Glargine insulin glargine INJECTION, SOLUTION SUBCUTANEOUS 20221021 N/A BLA BLA021081 A-S Medication Solutions INSULIN GLARGINE 100 [iU]/mL 1 VIAL, GLASS in 1 CARTON (50090-6184-0) / 10 mL in 1 VIAL, GLASS
50090-6178-0 50090-6178 HUMAN PRESCRIPTION DRUG Insulin Glargine Solostar insulin glargine INJECTION, SOLUTION SUBCUTANEOUS 20221019 N/A BLA BLA021081 A-S Medication Solutions INSULIN GLARGINE 100 [iU]/mL 5 SYRINGE in 1 CARTON (50090-6178-0) / 3 mL in 1 SYRINGE
0088-2220-33 0088-2220 HUMAN PRESCRIPTION DRUG Lantus insulin glargine INJECTION, SOLUTION SUBCUTANEOUS 20090923 N/A BLA BLA021081 sanofi-aventis U.S. LLC INSULIN GLARGINE 100 [iU]/mL 1 VIAL, GLASS in 1 CARTON (0088-2220-33) / 10 mL in 1 VIAL, GLASS
0088-5021-01 0088-5021 HUMAN PRESCRIPTION DRUG Lantus insulin glargine INJECTION, SOLUTION SUBCUTANEOUS 20170604 20240731 BLA BLA021081 sanofi-aventis U.S. LLC INSULIN GLARGINE 100 [iU]/mL 1 VIAL, GLASS in 1 PACKAGE (0088-5021-01) / 10 mL in 1 VIAL, GLASS
0088-2219-05 0088-2219 HUMAN PRESCRIPTION DRUG Lantus Solostar insulin glargine INJECTION, SOLUTION SUBCUTANEOUS 20090923 N/A BLA BLA021081 sanofi-aventis U.S. LLC INSULIN GLARGINE 100 [iU]/mL 5 SYRINGE in 1 CARTON (0088-2219-05) / 3 mL in 1 SYRINGE (0088-2219-01)
0088-2219-00 0088-2219 HUMAN PRESCRIPTION DRUG Lantus Solostar insulin glargine INJECTION, SOLUTION SUBCUTANEOUS 20090923 N/A BLA BLA021081 sanofi-aventis U.S. LLC INSULIN GLARGINE 100 [iU]/mL 1 SYRINGE in 1 CARTON (0088-2219-00) / 3 mL in 1 SYRINGE
0088-2220-34 0088-2220 HUMAN PRESCRIPTION DRUG Lantus insulin glargine INJECTION, SOLUTION SUBCUTANEOUS 20090923 N/A BLA BLA021081 sanofi-aventis U.S. LLC INSULIN GLARGINE 100 [iU]/mL 1 VIAL, GLASS in 1 CARTON (0088-2220-34) / 10 mL in 1 VIAL, GLASS
50090-0876-0 50090-0876 HUMAN PRESCRIPTION DRUG Lantus insulin glargine INJECTION, SOLUTION SUBCUTANEOUS 20141128 N/A BLA BLA021081 A-S Medication Solutions INSULIN GLARGINE 100 [iU]/mL 10 mL in 1 VIAL, GLASS (50090-0876-0)
50090-1398-0 50090-1398 HUMAN PRESCRIPTION DRUG Lantus Solostar insulin glargine INJECTION, SOLUTION SUBCUTANEOUS 20141128 N/A BLA BLA021081 A-S Medication Solutions INSULIN GLARGINE 100 [iU]/mL 5 SYRINGE in 1 PACKAGE (50090-1398-0) / 3 mL in 1 SYRINGE
50090-4068-0 50090-4068 HUMAN PRESCRIPTION DRUG LANTUS SOLOSTAR insulin glargine INJECTION, SOLUTION SUBCUTANEOUS 20190117 N/A BLA BLA021081 A-S Medication Solutions INSULIN GLARGINE 100 [iU]/mL 5 SYRINGE in 1 CARTON (50090-4068-0) / 3 mL in 1 SYRINGE
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase